Frank Rimerman Advisors LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Frank Rimerman Advisors LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,890 shares of the medical equipment provider’s stock after purchasing an additional 60 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Intuitive Surgical were worth $5,684,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at $31,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Bernstein Bank upped their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Truist Financial upped their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Raymond James upped their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $484.44 on Friday. The business’s 50 day moving average price is $567.46 and its 200-day moving average price is $531.26. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market cap of $172.55 billion, a price-to-earnings ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.